Allied Biotech Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	94.59	100.94	97.41	146.74	13.04	79.47
Depreciation & Amortization	61.14	61.94	69.45	71.76	65.24	61.63
Loss (Gain) From Sale of Assets	0.86	-	-	1.59	-	0.23
Loss (Gain) From Sale of Investments	-	-	-	-	-	-2.33
Provision & Write-off of Bad Debts	0.8	-	-	2	-	1.17
Other Operating Activities	-6.21	-2.7	-16.62	31.82	-9.13	2.33
Change in Accounts Receivable	-2.65	-21.69	8.62	-16.2	13.7	-43.24
Change in Inventory	20.75	73.94	-5	-88.39	-22.84	-46.29
Change in Accounts Payable	-1.6	-1.4	-10.69	-0.41	10.7	3.78
Change in Unearned Revenue	-2.59	-2.04	3.39	-0.34	0.88	-0.06
Change in Other Net Operating Assets	3.59	14.8	-8.95	15.7	0.83	2.78
Operating Cash Flow	168.68	223.79	137.62	164.27	72.43	59.48
Operating Cash Flow Growth	-22.67%	62.62%	-16.23%	126.81%	21.77%	-48.92%
Capital Expenditures	-31.05	-26.81	-47.91	-54.66	-49.99	-56.82
Sale of Property, Plant & Equipment	-	-	-	0.11	-	0.01
Investment in Securities	-19.47	97.37	6.98	273.57	-130.95	91.11
Other Investing Activities	0	-0.02	-0.01	-	-	-0.45
Investing Cash Flow	-50.51	70.55	-40.94	219.02	-180.94	33.84
Short-Term Debt Issued	-	170	-	-	265	320
Long-Term Debt Issued	-	58.87	-	107.68	-	144.3
Total Debt Issued	110	228.87	-	107.68	265	464.3
Short-Term Debt Repaid	-	-	-20	-390	-	-
Long-Term Debt Repaid	-	-82.99	-24.17	-132.32	-24.76	-168.74
Total Debt Repaid	-24.08	-82.99	-44.17	-522.32	-24.76	-168.74
Net Debt Issued (Repaid)	85.92	145.88	-44.17	-414.64	240.24	295.56
Common Dividends Paid	-96.02	-81.42	-114.46	-47.68	-76.12	-94.89
Other Financing Activities	0.73	0.48	0.3	0.32	0.12	-
Financing Cash Flow	-9.38	64.94	-158.33	-462	164.24	200.67
Foreign Exchange Rate Adjustments	-0.47	0.56	0.39	1.07	-1.82	0.7
Net Cash Flow	108.33	359.84	-61.26	-77.64	53.91	294.69
Free Cash Flow	137.63	196.98	89.71	109.62	22.44	2.66
Free Cash Flow Growth	-27.53%	119.58%	-18.16%	388.49%	744.88%	-96.42%
Free Cash Flow Margin	16.75%	24.41%	12.45%	15.29%	3.32%	0.43%
Free Cash Flow Per Share	1.43	2.04	0.94	1.14	0.23	0.03
Cash Interest Paid	17.2	13.58	12.87	11.65	11.06	8.91
Cash Income Tax Paid	30.27	32.55	40.65	5.66	13.88	20.34
Levered Free Cash Flow	-	135.02	33.04	17.52	65.85	-15.8
Unlevered Free Cash Flow	-	143.74	41.13	24.86	72.88	-10.17
Change in Working Capital	17.5	63.61	-12.63	-89.63	3.28	-83.02

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.